(Z)-3-(3,4-Dihydroxyphenyl)propenoic acid 2-phenylethyl ester
Internal ID | 0078c915-8989-4620-b83d-6868c44c9d27 |
Taxonomy | Phenylpropanoids and polyketides > Cinnamic acids and derivatives > Hydroxycinnamic acids and derivatives > Coumaric acids and derivatives |
IUPAC Name | 2-phenylethyl (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoate |
SMILES (Canonical) | C1=CC=C(C=C1)CCOC(=O)C=CC2=CC(=C(C=C2)O)O |
SMILES (Isomeric) | C1=CC=C(C=C1)CCOC(=O)/C=C\C2=CC(=C(C=C2)O)O |
InChI | InChI=1S/C17H16O4/c18-15-8-6-14(12-16(15)19)7-9-17(20)21-11-10-13-4-2-1-3-5-13/h1-9,12,18-19H,10-11H2/b9-7- |
InChI Key | SWUARLUWKZWEBQ-CLFYSBASSA-N |
Popularity | 0 references in papers |
Molecular Formula | C17H16O4 |
Molecular Weight | 284.31 g/mol |
Exact Mass | 284.10485899 g/mol |
Topological Polar Surface Area (TPSA) | 66.80 Ų |
XlogP | 4.20 |
Atomic LogP (AlogP) | 2.90 |
H-Bond Acceptor | 4 |
H-Bond Donor | 2 |
Rotatable Bonds | 5 |
(Z)-3-(3,4-Dihydroxyphenyl)propenoic acid 2-phenylethyl ester |
2-phenylethyl (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoate |
Lopac-C-8221 |
phenethyl (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoate |
CHEMBL1397711 |
AKOS025401276 |
NCGC00015274-01 |
![2D Structure of (Z)-3-(3,4-Dihydroxyphenyl)propenoic acid 2-phenylethyl ester 2D Structure of (Z)-3-(3,4-Dihydroxyphenyl)propenoic acid 2-phenylethyl ester](https://plantaedb.com/storage/docs/compounds/2023/07/z-3-34-dihydroxyphenylpropenoic-acid-2-phenylethyl-ester.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9551 | 95.51% |
Caco-2 | + | 0.5000 | 50.00% |
Blood Brain Barrier | - | 0.5250 | 52.50% |
Human oral bioavailability | - | 0.6429 | 64.29% |
Subcellular localzation | Mitochondria | 0.9106 | 91.06% |
OATP2B1 inhibitior | - | 0.8603 | 86.03% |
OATP1B1 inhibitior | + | 0.9419 | 94.19% |
OATP1B3 inhibitior | + | 0.9479 | 94.79% |
MATE1 inhibitior | + | 0.8200 | 82.00% |
OCT2 inhibitior | - | 0.9500 | 95.00% |
BSEP inhibitior | + | 0.6955 | 69.55% |
P-glycoprotein inhibitior | - | 0.9257 | 92.57% |
P-glycoprotein substrate | - | 0.9509 | 95.09% |
CYP3A4 substrate | - | 0.5560 | 55.60% |
CYP2C9 substrate | - | 0.5898 | 58.98% |
CYP2D6 substrate | - | 0.8417 | 84.17% |
CYP3A4 inhibition | - | 0.8309 | 83.09% |
CYP2C9 inhibition | + | 0.5955 | 59.55% |
CYP2C19 inhibition | + | 0.8042 | 80.42% |
CYP2D6 inhibition | - | 0.8592 | 85.92% |
CYP1A2 inhibition | + | 0.9107 | 91.07% |
CYP2C8 inhibition | + | 0.7825 | 78.25% |
CYP inhibitory promiscuity | - | 0.6362 | 63.62% |
UGT catelyzed | + | 0.6000 | 60.00% |
Carcinogenicity (binary) | - | 0.8341 | 83.41% |
Carcinogenicity (trinary) | Non-required | 0.6651 | 66.51% |
Eye corrosion | - | 0.9912 | 99.12% |
Eye irritation | + | 0.9133 | 91.33% |
Skin irritation | - | 0.8112 | 81.12% |
Skin corrosion | - | 0.9742 | 97.42% |
Ames mutagenesis | - | 0.7900 | 79.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.4889 | 48.89% |
Micronuclear | - | 0.6008 | 60.08% |
Hepatotoxicity | - | 0.5750 | 57.50% |
skin sensitisation | + | 0.4757 | 47.57% |
Respiratory toxicity | - | 0.7556 | 75.56% |
Reproductive toxicity | - | 0.5111 | 51.11% |
Mitochondrial toxicity | - | 0.7625 | 76.25% |
Nephrotoxicity | - | 0.8852 | 88.52% |
Acute Oral Toxicity (c) | III | 0.7989 | 79.89% |
Estrogen receptor binding | + | 0.9485 | 94.85% |
Androgen receptor binding | + | 0.9588 | 95.88% |
Thyroid receptor binding | - | 0.5994 | 59.94% |
Glucocorticoid receptor binding | - | 0.5000 | 50.00% |
Aromatase binding | + | 0.7899 | 78.99% |
PPAR gamma | + | 0.7256 | 72.56% |
Honey bee toxicity | - | 0.8406 | 84.06% |
Biodegradation | - | 0.6500 | 65.00% |
Crustacea aquatic toxicity | - | 0.5800 | 58.00% |
Fish aquatic toxicity | + | 0.9828 | 98.28% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL5983 | O60218 | Aldo-keto reductase family 1 member B10 |
46 nM |
Ki |
via Super-PRED
|
CHEMBL1900 | P15121 | Aldose reductase |
570 nM |
IC50 |
via Super-PRED
|
CHEMBL3687 | P18054 | Arachidonate 12-lipoxygenase |
14125.4 nM |
Potency |
via CMAUP
|
CHEMBL2903 | P16050 | Arachidonate 15-lipoxygenase |
794.3 nM 794.3 nM 130 nM |
Potency Potency IC50 |
via Super-PRED
via CMAUP via Super-PRED |
CHEMBL215 | P09917 | Arachidonate 5-lipoxygenase |
970 nM |
IC50 |
via Super-PRED
|
CHEMBL4096 | P04637 | Cellular tumor antigen p53 |
12589.3 nM 31622.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL221 | P23219 | Cyclooxygenase-1 |
833 nM |
IC50 |
via Super-PRED
|
CHEMBL3356 | P05177 | Cytochrome P450 1A2 |
1000 nM |
AC50 |
via CMAUP
|
CHEMBL3622 | P33261 | Cytochrome P450 2C19 |
12589.25 nM |
AC50 |
via CMAUP
|
CHEMBL3397 | P11712 | Cytochrome P450 2C9 |
39810.7 nM |
Potency |
via CMAUP
|
CHEMBL289 | P10635 | Cytochrome P450 2D6 |
39810.7 nM |
Potency |
via CMAUP
|
CHEMBL340 | P08684 | Cytochrome P450 3A4 |
15848.9 nM 15848.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL4159 | Q99714 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
19952.6 nM 12589.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha |
5011.9 nM 5011.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL4040 | P28482 | MAP kinase ERK2 |
25118.9 nM |
Potency |
via CMAUP
|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit |
2238.7 nM 2238.7 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1075189 | P14618 | Pyruvate kinase isozymes M1/M2 |
25118.9 nM 25118.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR |
656.1 nM |
Potency |
via Super-PRED
|
CHEMBL1293256 | P40225 | Thrombopoietin |
251.2 nM 251.2 nM 251.2 nM |
Potency Potency Potency |
via Super-PRED
via CMAUP via CMAUP |
CHEMBL1963 | P16473 | Thyroid stimulating hormone receptor |
5011.9 nM 5011.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.30% | 91.11% |
CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 98.07% | 94.62% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 97.63% | 86.33% |
CHEMBL1951 | P21397 | Monoamine oxidase A | 93.44% | 91.49% |
CHEMBL2581 | P07339 | Cathepsin D | 90.40% | 98.95% |
CHEMBL3194 | P02766 | Transthyretin | 90.12% | 90.71% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 89.73% | 96.09% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 89.15% | 99.17% |
CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 88.67% | 91.71% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 88.46% | 95.56% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 87.78% | 96.00% |
CHEMBL2085 | P14174 | Macrophage migration inhibitory factor | 86.46% | 80.78% |
CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 82.18% | 100.00% |
CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 81.18% | 95.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Ephedra sinica |
Pleurolobus gangeticus |
Sida cordifolia |
PubChem | 6603789 |
NPASS | NPC141791 |
ChEMBL | CHEMBL1397711 |